These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 32473614)

  • 41. Small nucleolar RNA ACA11 promotes proliferation, migration and invasion in hepatocellular carcinoma by targeting the PI3K/AKT signaling pathway.
    Wu L; Zheng J; Chen P; Liu Q; Yuan Y
    Biomed Pharmacother; 2017 Jun; 90():705-712. PubMed ID: 28419966
    [TBL] [Abstract][Full Text] [Related]  

  • 42. miR-493-5p suppresses hepatocellular carcinoma cell proliferation through targeting GP73.
    Zhao J; Xu T; Wang F; Cai W; Chen L
    Biomed Pharmacother; 2017 Jun; 90():744-751. PubMed ID: 28419971
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Decreased STAT4 indicates poor prognosis and enhanced cell proliferation in hepatocellular carcinoma.
    Wang G; Chen JH; Qiang Y; Wang DZ; Chen Z
    World J Gastroenterol; 2015 Apr; 21(13):3983-93. PubMed ID: 25852285
    [TBL] [Abstract][Full Text] [Related]  

  • 44. RBM38 plays a tumor-suppressor role via stabilizing the p53-mdm2 loop function in hepatocellular carcinoma.
    Ye J; Liang R; Bai T; Lin Y; Mai R; Wei M; Ye X; Li L; Wu F
    J Exp Clin Cancer Res; 2018 Sep; 37(1):212. PubMed ID: 30176896
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Downregulation of RIP140 in hepatocellular carcinoma promoted the growth and migration of the cancer cells.
    Zhang D; Wang Y; Dai Y; Wang J; Suo T; Pan H; Liu H; Shen S; Liu H
    Tumour Biol; 2015 Mar; 36(3):2077-85. PubMed ID: 25391428
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Upregulation of CENPM promotes hepatocarcinogenesis through mutiple mechanisms.
    Xiao Y; Najeeb RM; Ma D; Yang K; Zhong Q; Liu Q
    J Exp Clin Cancer Res; 2019 Nov; 38(1):458. PubMed ID: 31703591
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The potential contributions of a Y-located protooncogene and its X homologue in sexual dimorphisms in hepatocellular carcinoma.
    Kido T; Lo RC; Li Y; Lee J; Tabatabai ZL; Ng IO; Lau YF
    Hum Pathol; 2014 Sep; 45(9):1847-58. PubMed ID: 25017435
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Loss of RDM1 enhances hepatocellular carcinoma progression via p53 and Ras/Raf/ERK pathways.
    Chen SL; Liu LL; Wang CH; Lu SX; Yang X; He YF; Zhang CZ; Yun JP
    Mol Oncol; 2020 Feb; 14(2):373-386. PubMed ID: 31670863
    [TBL] [Abstract][Full Text] [Related]  

  • 49. MYO18B promotes hepatocellular carcinoma progression by activating PI3K/AKT/mTOR signaling pathway.
    Zhang Z; Zhu J; Huang Y; Li W; Cheng H
    Diagn Pathol; 2018 Nov; 13(1):85. PubMed ID: 30390677
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Progesterone receptor membrane component 1 as a potential prognostic biomarker for hepatocellular carcinoma.
    Tsai HW; Ho CL; Cheng SW; Lin YJ; Chen CC; Cheng PN; Yen CJ; Chang TT; Chiang PM; Chan SH; Ho CH; Chen SH; Wang YW; Chow NH; Lin JC
    World J Gastroenterol; 2018 Mar; 24(10):1152-1166. PubMed ID: 29563759
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Expression and Clinical Role of Cdc5L as a Novel Cell Cycle Protein in Hepatocellular Carcinoma.
    Qiu H; Zhang X; Ni W; Shi W; Fan H; Xu J; Chen Y; Ni R; Tao T
    Dig Dis Sci; 2016 Mar; 61(3):795-805. PubMed ID: 26553251
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Up-regulation of miR-10b-3p promotes the progression of hepatocellular carcinoma cells via targeting CMTM5.
    Guan L; Ji D; Liang N; Li S; Sun B
    J Cell Mol Med; 2018 Jul; 22(7):3434-3441. PubMed ID: 29691981
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The C/D box small nucleolar RNA SNORD52 regulated by Upf1 facilitates Hepatocarcinogenesis by stabilizing CDK1.
    Li C; Wu L; Liu P; Li K; Zhang Z; He Y; Liu Q; Jiang P; Yang Z; Liu Z; Yuan Y; Chang L
    Theranostics; 2020; 10(20):9348-9363. PubMed ID: 32802196
    [No Abstract]   [Full Text] [Related]  

  • 54. Eukaryotic elongation factor-1α 2 knockdown inhibits hepatocarcinogenesis by suppressing PI3K/Akt/NF-κB signaling.
    Qiu FN; Huang Y; Chen DY; Li F; Wu YA; Wu WB; Huang XL
    World J Gastroenterol; 2016 Apr; 22(16):4226-37. PubMed ID: 27122673
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Inactivation of fatty acid synthase impairs hepatocarcinogenesis driven by AKT in mice and humans.
    Li L; Pilo GM; Li X; Cigliano A; Latte G; Che L; Joseph C; Mela M; Wang C; Jiang L; Ribback S; Simile MM; Pascale RM; Dombrowski F; Evert M; Semenkovich CF; Chen X; Calvisi DF
    J Hepatol; 2016 Feb; 64(2):333-341. PubMed ID: 26476289
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Testis-specific protein, Y-linked 1 activates PI3K/AKT and RAS signaling pathways through suppressing IGFBP3 expression during tumor progression.
    Tu W; Yang B; Leng X; Pei X; Xu J; Liu M; Dong Q; Tao D; Lu Y; Liu Y; Yang Y
    Cancer Sci; 2019 May; 110(5):1573-1586. PubMed ID: 30815935
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Myc/Max dependent intronic long antisense noncoding RNA, EVA1A-AS, suppresses the expression of Myc/Max dependent anti-proliferating gene EVA1A in a U2 dependent manner.
    Niehus SE; Allister AB; Hoffmann A; Wiehlmann L; Tamura T; Tran DDH
    Sci Rep; 2019 Nov; 9(1):17319. PubMed ID: 31754186
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The tumor suppressor DLC1 inhibits cancer progression and oncogenic autophagy in hepatocellular carcinoma.
    Wu HT; Xie CR; Lv J; Qi HQ; Wang F; Zhang S; Fang QL; Wang FQ; Lu YY; Yin ZY
    Lab Invest; 2018 Aug; 98(8):1014-1024. PubMed ID: 29785050
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Clinical and biological significance of transcription termination factor, RNA polymerase I in human liver hepatocellular carcinoma.
    Komatsu H; Iguchi T; Ueda M; Nambara S; Saito T; Hirata H; Sakimura S; Takano Y; Uchi R; Shinden Y; Eguchi H; Masuda T; Sugimachi K; Eguchi H; Doki Y; Mori M; Mimori K
    Oncol Rep; 2016 Apr; 35(4):2073-80. PubMed ID: 26821084
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A novel lncRNA MCM3AP-AS1 promotes the growth of hepatocellular carcinoma by targeting miR-194-5p/FOXA1 axis.
    Wang Y; Yang L; Chen T; Liu X; Guo Y; Zhu Q; Tong X; Yang W; Xu Q; Huang D; Tu K
    Mol Cancer; 2019 Feb; 18(1):28. PubMed ID: 30782188
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.